National Capital Consortium Urology

Topics

• Prostate Cancer Diagnosis and Treatment 514
• Bladder and Urothelial Cancer Treatments 198
• Prostate Cancer Treatment and Research 123
• Renal cell carcinoma treatment 102
• Testicular diseases and treatments 78
• Sexual function and dysfunction studies 40
• Urological Disorders and Treatments 36
• Kidney Stones and Urolithiasis Treatments 30
• Urinary Bladder and Prostate Research 25
• Urologic and reproductive health conditions 14
• Cancer survivorship and care 13
• Pelvic floor disorders treatments 13

Most cited

1. Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification.

   Prostate cancer and prostatic diseases · 2024 · 126 citations · Judd Moul

2. Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial.

   European urology · 2026 · 17 citations · Abhinav Sidana

3. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 101 citations · Timothy Donahue

4. Predicting Response to Intravesical Bacillus Calmette-Guérin in High-Risk Nonmuscle-Invasive Bladder Cancer Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center Cohort.

   The Journal of urology · 2025 · 31 citations · Thomas Gerald

5. Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG).

   European urology oncology · 2025 · 25 citations · Mark Soloway

6. International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder Cancer.